CRISPR-Cas Systems Reduced to a Minimum.

CRISPR-Cas Systems Gene Editing

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
21 02 2019
Historique:
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 14 6 2019
Statut: ppublish

Résumé

In two recent studies in Molecular Cell, Wright et al. (2019) report complete spacer integration by a Cas1 mini-integrase and Edraki et al. (2019) describe accurate genome editing by a small Cas9 ortholog with less stringent PAM requirements.

Identifiants

DOI: 10.1016/j.molcel.2019.02.005 PMID: 30794791
pubmed: 30794791
pii: S1097-2765(19)30095-4
doi: 10.1016/j.molcel.2019.02.005
pii:
doi:

Types de publication

Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-642

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Cristóbal Almendros (C)

Kavli Institute of Nanoscience, Department of Bionanoscience, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, the Netherlands.

Sebastian N Kieper (SN)

Kavli Institute of Nanoscience, Department of Bionanoscience, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, the Netherlands.

Stan J J Brouns (SJJ)

Kavli Institute of Nanoscience, Department of Bionanoscience, Delft University of Technology, Van der Maasweg 9, 2629 HZ Delft, the Netherlands; Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE Wageningen, the Netherlands. Electronic address: stanbrouns@gmail.com.

Articles similaires

Generation of isogenic models of Angelman syndrome and Prader-Willi syndrome in CRISPR/Cas9-engineered human embryonic stem cells.

Rachel B Gilmore, Dea Gorka, Christopher E Stoddard et al.
1.00
Prader-Willi Syndrome Humans Angelman Syndrome CRISPR-Cas Systems Human Embryonic Stem Cells

Genome editing in Sub-Saharan Africa: a game-changing strategy for climate change mitigation and sustainable agriculture.

Peter Amoah, Abdoul-Razak Oumarou Mahamane, Moise Hubert Byiringiro et al.
1.00
Gene Editing Climate Change Africa South of the Sahara Crops, Agricultural Agriculture

Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina.

Satheesh Kumar, Yi-Wen Hsiao, Vickie H Y Wong et al.
1.00
Animals Humans CRISPR-Cas Systems Mice Vascular Endothelial Growth Factor A

Opportunities for CRISPR-Cas9 application in farm animal genetic improvement.

Dalia M Aboelhassan, Hesham Abozaid
1.00
Animals CRISPR-Cas Systems Gene Editing Animals, Genetically Modified Livestock

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Épigenèse génétique › Extinction de l'expression des gènes › Systèmes CRISPR-Cas › CRISPR-Cas Systems Reduced to a Minimum.
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Génie génétique › Édition de gène › CRISPR-Cas Systems Reduced to a Minimum.